Financhill
Sell
46

ACAD Quote, Financials, Valuation and Earnings

Last price:
$17.89
Seasonality move :
9.57%
Day range:
$17.62 - $18.00
52-week range:
$14.15 - $29.29
Dividend yield:
0%
P/E ratio:
22.94x
P/S ratio:
3.19x
P/B ratio:
5.16x
Volume:
1.1M
Avg. volume:
3.4M
1-year change:
-34.44%
Market cap:
$3B
Revenue:
$726.4M
EPS (TTM):
$0.78

Earnings Data

Next earnings date for ACAD
Feb 27
2025
Most recent earnings per share
$0.20
Beat by $0.06
(Nov 6/2024)
Consensus Estimate
$0.14
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ACAD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $237.1M -- -- $0.02 --
02/27/2025 Q4 $279M -- -- $0.21 --
11/06/2024 Q3 $248.8M $250.4M $0.20 $0.14 $0.06
08/06/2024 Q2 $235.7M $242M $0.20 $0.18 $0.02
05/08/2024 Q1 $208.6M $205.8M $0.10 $0.06 $0.04
02/27/2024 Q4 $223.8M $231M $0.28 $0.31 -$0.03
11/02/2023 Q3 -- -- -$0.40 -$0.42 $0.02
08/02/2023 Q2 -- -- $0.01 -$0.12 $0.13
05/08/2023 Q1 -- -- -$0.27 -$0.21 -$0.06
02/27/2023 Q4 -- -- -$0.26 -$0.25 -$0.01
11/02/2022 Q3 -- -- -$0.17 -$0.20 $0.03
08/08/2022 Q2 -- -- -$0.21 -$0.25 $0.04
05/04/2022 Q1 -- -- -$0.70 -$0.60 -$0.10
02/28/2022 Q4 -- -- -$0.27 -$0.24 -$0.03
11/08/2021 Q3 -- -- -$0.09 -$0.26 $0.17
08/04/2021 Q2 -- -- -$0.27 -$0.30 $0.03
05/05/2021 Q1 -- -- -$0.42 -- --
02/24/2021 Q4 -- -- -$0.42 -- --
11/04/2020 Q3 -- -- -$0.54 -- --
08/05/2020 Q2 -- -- -$0.27 -- --
05/07/2020 Q1 -- -- -$0.57 -- --
02/26/2020 Q4 -- -- -$0.34 -- --
10/30/2019 Q3 -- -- -$0.29 -- --
07/31/2019 Q2 -- -- -$0.38 -- --
05/01/2019 Q1 -- -- -$0.59 -- --
02/26/2019 Q4 -- -- -$0.50 -- --
11/06/2018 Q3 -- -- -$0.50 -- --
08/08/2018 Q2 -- -- -$0.51 -- --
05/04/2018 Q1 -- -- -$0.44 -- --
02/27/2018 Q4 -- -- -$0.55 -- --
11/07/2017 Q3 -- -- -$0.53 -- --
08/08/2017 Q2 -- -- -$0.55 -- --
05/09/2017 Q1 -- -- -$0.72 -- --
02/28/2017 Q4 -- -- -$0.65 -- --
11/07/2016 Q3 -- -- -$0.61 -- --
08/04/2016 Q2 -- -- -$0.63 -- --
05/05/2016 Q1 -- -- -$0.45 -- --
02/29/2016 Q4 -- -- -$0.45 -- --
10/29/2015 Q3 -- -- -$0.39 -- --
08/06/2015 Q2 -- -- -$0.39 -- --
05/07/2015 Q1 -- -- -$0.40 -- --

ACADIA Pharmaceuticals Earnings Questions

  • How Much did ACADIA Pharmaceuticals Generate in Revenue Last Quarter?

    ACADIA Pharmaceuticals reported $250.4M worth of top line sales in its most recent quarter.

  • Did ACADIA Pharmaceuticals Beat Earnings Last Quarter?

    ACADIA Pharmaceuticals announced earnings per share of $0.20 which represents a beat of analyst forecast a $0.14 per share.

  • Is ACADIA Pharmaceuticals Profitable?

    ACADIA Pharmaceuticals reported $231.5M that represents $1.39 per share over the last quarter.

  • What is the Analyst Consensus for ACADIA Pharmaceuticals EPS Next Year?

    ACADIA Pharmaceuticals's earnings are forecast to decrease from -$0.37 per share to $0.70 per share next year representing a decrease of -75.16%.

  • When is ACADIA Pharmaceuticals's Earnings Date?

    ACADIA Pharmaceuticals's next earnings date is February 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Quantum Stocks Should I Buy?
What Quantum Stocks Should I Buy?

The last several years have seen a series of tech…

Will Sirius XM Be a 10-Bagger Stock?
Will Sirius XM Be a 10-Bagger Stock?

Last year, Warren Buffett surprised practically everyone when he acquired…

Will Quantum Computing Disrupt NVIDIA?
Will Quantum Computing Disrupt NVIDIA?

Earlier this month, NVIDIA CEO Jensen Huang seemingly dashed the…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Buy
59
NUKK alert for Jan 22

Nukkleus [NUKK] is up 7.25% over the past day.

Sell
32
FTAI alert for Jan 22

FTAI Aviation [FTAI] is down 25.44% over the past day.

Sell
2
EDU alert for Jan 22

New Oriental Education & Technology Group [EDU] is down 23.18% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock